Home RxNorm 1811632 aspirin 325 MG / omeprazole 40 MG Delayed Release Oral Tablet Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 1811632
RxNorm name aspirin 325 MG / omeprazole 40 MG Delayed Release Oral Tablet
Display name Aspirin/Omeprazole (Oral Pill)
Full name aspirin 325 MG / omeprazole 40 MG Delayed Release Oral Tablet
Term type SCD
Status Active
Strength 325-40 mg
Dose form DR Tab
Route Oral Pill
Updated 2026-10-24 12:48:59 RxNorm Status History#
Status Active
Source RXNORM
Current YES
Release start 112016
Active start 112016
Multiple ingredient YES
Branded NO Ingredients And Strength# Ingredient, Strength, Base table Ingredient Strength Base Basis of strength aspirin 325 MG / 1 EACH aspirin aspirin omeprazole 40 MG / 1 EACH omeprazole omeprazole
Derived Ingredient Concepts# RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.
NDC11, Source, Active table NDC11 Source Active 71800001830 rxnav_historical
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 73f74f6d-e624-4551-8924-1c747ffb2140 aspirin 325 MG / omeprazole 40 MG Delayed Release Oral Tablet [PSN] · aspirin 325 MG / omeprazole 40 MG Delayed Release Oral Tablet [SCD] · ASA 325 MG / Omeprazole 40 MG Delayed Release Oral Tablet [SY] 3 4 These highlights do not include all the information needed to use YOSPRALA safely and effectively. See full prescribing information for YOSPRALA . YOSPRALA (aspirin and omeprazole) delayed-release tablets, for oral use Initial U.S. Approval: 2016 20180619 bce0eb08-7eac-4437-ba88-fafac350a8f6 aspirin 325 MG / omeprazole 40 MG Delayed Release Oral Tablet [PSN] · aspirin 325 MG / omeprazole 40 MG Delayed Release Oral Tablet [SCD] · ASA 325 MG / Omeprazole 40 MG Delayed Release Oral Tablet [SY] 3 1 These highlights do not include all the information needed to use YOSPRALA™ safely and effectively. See full prescribing information for YOSPRALA. YOSPRALA (aspirin and omeprazole) delayed-release tablets, for oral use Initial U.S. Approval: 2016 20200130
Recently Linked DailyMed Labels# Set ID, Title, Manufacturer table Set ID Title Manufacturer Effective c8128830-ddc5-45f1-9eaa-7d078c5ea8d9 These highlights do not include all the information needed to use aspirin and omeprazole delayed-release tablets™ safely and effectively. See full prescribing information for aspirin and omeprazole delayed-release tablets. aspirin and omeprazole delayed-release tablets (aspirin and omeprazole) delayed-release tablets, for oral use Initial U.S. Approval: 2016 Innovida Phamaceutique Corporation | Patheon Pharmaceucticals 20211020
Properties# Category, Property, Value table Category Property Value ATTRIBUTES AVAILABLE_STRENGTH 325 MG / 40 MG ATTRIBUTES GENERAL_CARDINALITY MULTI ATTRIBUTES HUMAN_DRUG US ATTRIBUTES RXNAV_HUMAN_DRUG US ATTRIBUTES SCHEDULE 0 CODES VUID 4036079 NAMES Prescribable Synonym aspirin 325 MG / omeprazole 40 MG Delayed Release Oral Tablet SOURCES Source Multum MediSource Lexicon SOURCES Source National Drug Data File Plus Source Vocabulary SOURCES Source Veterans Health Administration National Drug File